Eur Rev Med Pharmacol Sci 2020; 24 (23): 11986-11986
DOI: 10.26355/eurrev_202012_23952

Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway

Z.-X. Guo, F.-Z. Zhou, W. Song, L.-L. Yu, W.-J. Yan, L.-H. Yin, H. Sang, H.-Y. Zhang

Department of Cardiology, Taian City Central Hospital, Taian, China.


The article “Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway, by Z.-X. Guo, F.-Z. Zhou, W. Song, L.-L. Yu, W.-J. Yan, L.-H. Yin, H. Sang, H.-Y. Zhang, published in Eur Rev Med Pharmacol Sci 2018; 22 (20): 6965-6976–DOI: 10.26355/eurrev_201810_16167–PMID: 30402863” has been withdrawn from the authors due to some inaccuracies.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/16167

Free PDF Download

To cite this article

Z.-X. Guo, F.-Z. Zhou, W. Song, L.-L. Yu, W.-J. Yan, L.-H. Yin, H. Sang, H.-Y. Zhang
Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 23
Pages: 11986-11986
DOI: 10.26355/eurrev_202012_23952